BioInsights - Preclinical/translational tools and strategies - spotlight

CELL & GENE THERAPY INSIGHTS

Preclinical/translational tools and strategies

Bruce Bunnell

Guest Editor:

Bruce Bunnell, Professor and Chair at UNT Health Science Center

February 2021

Download full spotlight

On a mission to bring single-cell sequencing to cell and gene therapy

C Silver

24 February 2021

Interview

Read more
Preclinical/translational tools & strategies

B Bunnell

24 February 2021

Foreword

Read more
On a mission to bring single-cell sequencing to cell and gene therapy

C Silver

24 February 2021

Podcast

Listen now
Accelerating preclinical development for AAV based gene therapies: bridging the gap between discovery and clinical development

L Rodino-Klapac

24 February 2021

Editorial

Read more
Expediting novel ex vivo HSC gene therapies to the clinic: a preclinical perspective

G Leoni,

A Lambert,

C Hudson et al.

24 February 2021

Commentary

Read more
Identify and select optimal T cell phenotypes

J Lovrgen

22 February 2021

FastFacts

Read more
Beginning gene therapy preclinical development with the end in mind: from preclinical to economic modelling

O Negre

16 February 2021

Interview

Read more
Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management

C Cossins,

P Fairchild

15 February 2021

Expert Insight

Read more
The T cell therapy field faces preclinical and translational R&D challenges as it targets more complex diseases

G Waanders,

S Raffegerst,

P Prinz-Schulz et al.

15 February 2021

Expert Insight

Read more
Animal models of disease: preclinical to clinical gene therapy translatability

E Matsumoto Plata,

C Plata-Salaman

11 February 2021

Expert Insight

Read more